Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Kenvue Inc. (KVUE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: KVUE (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit -10.01% | Avg. Invested days 27 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 45.64B USD | Price to earnings Ratio 44.22 | 1Y Target Price 24.25 |
Price to earnings Ratio 44.22 | 1Y Target Price 24.25 | ||
Volume (30-day avg) 16632199 | Beta - | 52 Weeks Range 17.18 - 24.36 | Updated Date 04/2/2025 |
52 Weeks Range 17.18 - 24.36 | Updated Date 04/2/2025 | ||
Dividends yield (FY) 3.43% | Basic EPS (TTM) 0.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 6.67% | Operating Margin (TTM) 23.43% |
Management Effectiveness
Return on Assets (TTM) 6.88% | Return on Equity (TTM) 9.87% |
Valuation
Trailing PE 44.22 | Forward PE 20.75 | Enterprise Value 53289428393 | Price to Sales(TTM) 2.95 |
Enterprise Value 53289428393 | Price to Sales(TTM) 2.95 | ||
Enterprise Value to Revenue 3.45 | Enterprise Value to EBITDA 21.59 | Shares Outstanding 1911239936 | Shares Floating 1908431196 |
Shares Outstanding 1911239936 | Shares Floating 1908431196 | ||
Percent Insiders 0.04 | Percent Institutions 102.45 |
Analyst Ratings
Rating 3.53 | Target Price 24.97 | Buy 3 | Strong Buy 3 |
Buy 3 | Strong Buy 3 | ||
Hold 11 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Kenvue Inc.
Company Overview
History and Background
Kenvue Inc. was spun off from Johnson & Johnson in May 2023, becoming a standalone consumer health company. J&J was founded in 1886. The separation allowed both companies to focus on their respective strategic priorities.
Core Business Areas
- Self Care: Focuses on over-the-counter medicines and supplements. Examples include pain relief, cough/cold remedies, allergy medications, digestive health and vitamins.
- Skin Health & Beauty: Offers products for skin care, sun care, and personal care. Includes brands focused on acne treatment, moisturizers, and sun protection.
- Essential Health: Provides products for baby care, oral care, wound care, and women's health. Encompasses items like diapers, toothpaste, bandages, and feminine hygiene products.
Leadership and Structure
Kenvue is led by CEO Thibaut Mongon. The company has a board of directors and a management team responsible for overseeing its various business units and functions.
Top Products and Market Share
Key Offerings
- Band-Aid: Adhesive bandages, market leader in the category. Competitors: 3M (Nexcare), CVS Health (store brand).
- Tylenol: Pain reliever, a top-selling brand. Competitors: Bayer (Aspirin), GlaxoSmithKline (Advil).
- Neutrogena: Skincare products, a well-known brand with a substantial market presence. Competitors: L'Oru00e9al (La Roche-Posay), Unilever (Dove).
- Listerine: Mouthwash, a leading brand in oral care. Competitors: Procter & Gamble (Crest), Colgate-Palmolive (Colgate).
Market Dynamics
Industry Overview
The consumer health industry is characterized by stable growth, driven by an aging population, increasing healthcare awareness, and a shift towards self-care. It is competitive with high innovation, new regulations and volatile supply chain issues.
Positioning
Kenvue is positioned as a leading consumer health company with a portfolio of well-established and trusted brands. It aims to leverage its brand equity and distribution network to maintain and expand its market share.
Total Addressable Market (TAM)
The global consumer health market is expected to reach hundreds of billions of dollars. Kenvue is positioned to capture a significant portion of this market through its diverse product portfolio and strong brand recognition.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio
- Extensive distribution network
- Established market presence
- Significant R&D capabilities
Weaknesses
- High dependence on key brands
- Potential for product liability issues
- Impact of consumer discretionary spending
- Limited novel products.
Opportunities
- Expanding into emerging markets
- Developing innovative products
- Acquiring complementary businesses
- Capitalizing on e-commerce growth
Threats
- Intense competition
- Changing consumer preferences
- Regulatory changes
- Economic downturns
Competitors and Market Share
Key Competitors
- PG
- CL
- UL
Competitive Landscape
Kenvue competes with a variety of established consumer health companies. Its advantages include strong brand recognition and a broad product portfolio. Disadvantages may include a higher cost structure versus some competitors or slower innovation in certain categories.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Kenvue's historical growth is reflected in the performance of Johnson & Johnson's consumer health division before the spin-off. A look at their annual report will detail this performance.
Future Projections: Future growth projections depend on market trends, product innovation, and strategic initiatives. Analyst estimates are available from financial news sources.
Recent Initiatives: Recent initiatives include new product launches, geographic expansion, and strategic partnerships.
Summary
Kenvue possesses a strong brand portfolio and established market presence, positioning it well within the competitive consumer health industry. The company's reliance on key brands and susceptibility to consumer spending patterns present challenges. Future growth will depend on successful innovation, strategic market expansion, and effective management of regulatory changes and economic pressures.
Similar Companies
CL
Colgate-Palmolive Company
CL
Colgate-Palmolive Company
HSY
Hershey Co
HSY
Hershey Co
PG
Procter & Gamble Company
PG
Procter & Gamble Company
Sources and Disclaimers
Data Sources:
- Kenvue Investor Relations
- SEC Filings (10K, 10Q)
- Market Research Reports
- Financial News Outlets
Disclaimers:
This analysis is based on publicly available information and analyst estimates. Actual results may vary. This is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kenvue Inc.
Exchange NYSE | Headquaters Summit, NJ, United States | ||
IPO Launch date 2023-05-04 | CEO & Director Mr. Thibaut Mongon | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 22000 | Website https://www.kenvue.com |
Full time employees 22000 | Website https://www.kenvue.com | ||
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.